City Therapeutics to Present CITY-FXI Phase 1 Data at ASH Annual Meeting

PUBT · 17h ago
City Therapeutics to Present CITY-FXI Phase 1 Data at ASH Annual Meeting
  • City Therapeutics will present at the 68th American Society of Hematology Annual Meeting in New Orleans, Dec. 12-15, 2026.
  • A Dec. 12 oral presentation will cover Phase 1 CITY-FXI data for thromboembolic diseases, including healthy volunteers and adults with clotting-related mutations.
  • A poster presentation on Dec. 12 will highlight preclinical CITY-TFR2 data supporting development for anemia of chronic disease.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. City Therapeutics Inc published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611040901PRIMZONEFULLFEED9869444) on November 04, 2026, and is solely responsible for the information contained therein.